India’s global trade strategy has entered a transformative phase with the conclusion of two landmark agreements in 2026:
- The India–US Bilateral Trade Agreement, unlocking access to a $30 trillion market
- The India–European Union Free Trade Agreement (FTA), covering a combined $24 trillion economy
For India’s chemical industry valued at over $247 billion and targeting $1 trillion by 2040 these agreements represent structural growth catalysts.
However, the advantages differ in nature, scope, and strategic orientation. We examine how both agreements impact the Indian chemical sector across bulk chemicals, specialty chemicals, agrochemicals, petrochemicals, and pharmaceutical intermediates.
India–EU FTA: Broad-Based Tariff Elimination for Chemicals
Comprehensive Duty Elimination
Under the India–EU FTA
- 97.5 per cent of India’s chemical export basket (by value) receives zero duty access
- Tariffs of up to 12.8 per cent are eliminated
- Coverage includes Organic chemicals, Inorganic chemicals, Agrochemicals, Plastics and rubber products, Downstream intermediates
The EU imports approximately $500 billion worth of chemicals annually, making it one of the world’s largest chemical markets.
Competitive Advantage
Immediate tariff elimination significantly enhances India’s price competitiveness in: Performance chemicals, Polymer intermediates, Agrochemical formulations, Fine and specialty chemicals.
Regulatory and Compliance Benefits
The FTA also strengthens the recognition of conformity assessment, reduced double testing requirements and alignment with international standards. This lowers compliance costs and improves ease of market entry for exporters.
Sustainability and Green Chemistry Alignment
With Europe’s strong regulatory focus on sustainability and green transition, Indian manufacturers investing in low-emission production, bio-based chemicals and sustainable intermediates stand to benefit significantly.
Key Takeaway
The EU FTA provides immediate, broad-based, and volume-driven export growth for India’s chemical industry.
India–US Agreement: Strategic and Technology-Driven Advantages
The India–US agreement adopts a more strategic and sector-specific framework, duty-Free Market Access Covering $38 Billion in Industrial Exports
Key benefits include:
- Reduction of reciprocal tariffs from 25 per cent to 18 per cent, improving price competitiveness
- Zero additional duty on selected industrial exports
- Relief under Section 232 provisions (End Use Basis)
- Preferential treatment across multiple tariff lines
This includes benefits for: Pharmaceutical ingredients, Agrochemical, Generic drug intermediates, Inorganic chemicals and Specialty industrial inputs.
Competitive Edge Over China and ASEAN
The US continues to maintain higher tariff rates on certain competing countries, including China, Vietnam, Bangladesh, Malaysia, Indonesia, Philippines, Cambodia and Thailand.
This creates a tariff differential advantage for Indian exporters, especially in: Pharma intermediates, Fine chemicals and Advanced materials.
Technology and Supply Chain Integration
A major strength of the US agreement lies in strategic cooperation:
- Semiconductor inputs
- Battery materials: Lithium compounds and cathode materials.
- Clean energy chemicals: Specialty chemicals, industrial enzymes, and fertiliser inputs (phosphate/potash).
- Specialty materials
This strengthens India’s position in: Electric vehicle battery chemicals, Electronics and semiconductor-linked chemicals and Advanced manufacturing supply chains.
Key Takeaway
The US agreement provides strategic, high-technology, and geopolitically aligned advantages, particularly for pharmaceutical and advanced chemical segments.
Sector-Wise Comparative Impact
|
Segment |
India–EU FTA |
India–US Agreement |
|
Bulk Chemicals |
Strong immediate gains |
Limited but selective |
|
Specialty Chemicals |
Very strong |
Strategic advantage |
|
Agrochemicals |
Broad coverage |
Strong |
|
Pharma Intermediates |
Competitive access |
High strategic gain |
|
Battery & Advanced Materials |
Moderate |
Strong |
Impact on MSMEs and Chemical Clusters
Under the EU FTA:
- Higher immediate margin expansion
- Lower compliance duplication
- Greater export predictability
- Improved integration into European value chains
Under the US Agreement:
- Strengthened export potential across agrochemicals, pharma intermediates, fine chemicals, semiconductor inputs, battery materials, and specialty chemical segments.
- Technology tie-ups and advanced manufacturing growth
- Access to high-value industrial inputs